Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Kauffman
Next Generation XPO1 Inhibitor Shows Improved Efficacy and in Vivo Tolerability in Hematologic Malignancies
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone
Cancer Letters
Cancer Research
Oncology
Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
Molecular Mechanism and Therapeutic Implications of Selinexor (KPT-330) in Liposarcoma
Oncotarget
Oncology
Selinexor Reduces the Expression of DNA Damage Repair Proteins and Sensitizes Cancer Cells to DNA Damaging Agents
Oncotarget
Oncology
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
PLoS ONE
Multidisciplinary
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185
PLoS ONE
Multidisciplinary
